[Treatment of tuberculosis patients with massive bacterial excretion].
A new endobronchial treatment has been developed for patients with destructive pulmonary tuberculosis with massive bacterial excretion, complicated by chronic nonspecific endobronchitis. The treatment includes inhalation therapy with antituberculous drugs dissolved in activated silver water. This treatment of 42 patients has shown more than 2-fold increases in the rate of massive bacterial excretion cessation.
Gavril'ev
S S
SS
NPO "Phthisiology", Iakutia.
Vinokurova
M K
MK
D000280:Administration, Inhalation; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use*; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification*; D013183:Sputum / Q000382:microbiology*; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
D000995:Antitubercular Agents; D007538:Isoniazid
Lechenie bol'nukh tuberkulezom legkikh s massivnym bakteriovydeleniem.